Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

freshpet - FRPT

FRPT

Close Chg Chg %
85.30 1.35 1.58%

Pre-Market

86.65

+1.35 (1.58%)

Volume: 788.77K

Last Updated:

Mar 27, 2025, 4:00 PM EDT

Trade Now

Company Overview: freshpet - FRPT

FRPT Key Data

Open

$84.62

 Day Range

83.68 - 87.77

52 Week Range

80.38 - 164.00

 Market Cap

$4.16B

Shares Outstanding

48.72M

 Public Float

48.02M

Beta

1.58

 Rev. Per Employee

N/A

P/E Ratio

92.35

 EPS

$0.97

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.20M

  

FRPT Performance

1 Week
 
 0.01%
 
1 Month
 
 -19.04%
 
3 Months
 
 -40.80%
 
1 Year
 
 -25.21%
 
5 Years
 
 47.01%
 

FRPT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 19
Full Ratings ➔

About freshpet - FRPT

Freshpet, Inc. engages in the manufacturing, marketing, and distribution of pet food and pet treats for dogs and cats. Its products are blends of fresh meats, vegetables, and fruits farmed locally and made at Freshpet kitchens. Its products include Deli Fresh Grain Free Chicken Recipe for Dogs, Joy Turkey and Apple Bites Treats, Nature's Fresh Grain Free Chicken Recipe for Cats, and Vital Grain Free Chicken and Ocean Whitefish Recipe for Cats. The company was founded by Scott Morris and Cathal Walsh in November 2004 and is headquartered in Bedminster, NJ.

FRPT At a Glance

Freshpet, Inc.
1545 US-206
Bedminster, New Jersey 07921
Phone 1-201-520-4000 Revenue 975.18M
Industry Food: Specialty/Candy Net Income 46.93M
Sector Consumer Non-Durables 2024 Sales Growth 27.159%
Fiscal Year-end 12 / 2025 Employees 1,296
View SEC Filings

FRPT Valuation

P/E Current 92.353
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 158.627
Price to Sales Ratio 7.633
Price to Book Ratio 6.835
Price to Cash Flow Ratio 48.243
Enterprise Value to EBITDA 67.724
Enterprise Value to Sales 7.792
Total Debt to Enterprise Value 0.056

FRPT Efficiency

Revenue/Employee 752,451.389
Income Per Employee 36,207.562
Receivables Turnover 14.253
Total Asset Turnover 0.642

FRPT Liquidity

Current Ratio 4.42
Quick Ratio 3.603
Cash Ratio 2.717

FRPT Profitability

Gross Margin 38.36
Operating Margin 3.957
Pretax Margin 4.873
Net Margin 4.812
Return on Assets 3.088
Return on Equity 4.672
Return on Total Capital 3.172
Return on Invested Capital 3.292

FRPT Capital Structure

Total Debt to Total Equity 40.184
Total Debt to Total Capital 28.665
Total Debt to Total Assets 26.928
Long-Term Debt to Equity 39.858
Long-Term Debt to Total Capital 28.433
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Freshpet - FRPT

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
425.49M 595.34M 766.89M 975.18M
Sales Growth
+33.47% +39.92% +28.82% +27.16%
Cost of Goods Sold (COGS) incl D&A
275.51M 423.09M 531.87M 601.10M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
31.80M 35.93M 58.52M 73.61M
Depreciation
30.80M 35.70M 58.17M 73.61M
Amortization of Intangibles
- 1.00M 223.00K 348.00K
COGS Growth
+42.08% +53.57% +25.71% +13.02%
Gross Income
149.98M 172.25M 235.02M 374.08M
Gross Income Growth
+20.09% +14.85% +36.44% +59.17%
Gross Profit Margin
+35.25% +28.93% +30.65% +38.36%
2021 2022 2023 2024 5-year trend
SG&A Expense
171.88M 223.10M 264.76M 335.49M
Research & Development
- - - -
-
Other SG&A
171.88M 223.10M 264.76M 335.49M
SGA Growth
+41.79% +29.80% +18.67% +26.71%
Other Operating Expense
- - - -
-
Unusual Expense
- 1.76M 734.00K (67.00K)
EBIT after Unusual Expense
(23.66M) (51.59M) (29.67M) 38.59M
Non Operating Income/Expense
(987.00K) 1.31M 12.26M 21.20M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - 9.92M
-
Interest Expense
2.88M 5.21M 14.10M 12.26M
Interest Expense Growth
+137.79% +80.71% +170.68% -13.02%
Gross Interest Expense
2.88M 5.21M 14.10M 12.26M
Interest Capitalized
- - - -
-
Pretax Income
(27.53M) (55.48M) (31.51M) 47.52M
Pretax Income Growth
-781.59% -101.51% +43.20% +250.80%
Pretax Margin
-6.47% -9.32% -4.11% +4.87%
Income Tax
162.00K 282.00K 210.00K 598.00K
Income Tax - Current - Domestic
162.00K 282.00K 210.00K 598.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - 9.92M
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(29.70M) (59.49M) (33.61M) 46.92M
Minority Interest Expense
- - - -
-
Net Income
(29.70M) (59.49M) (33.61M) 46.92M
Net Income Growth
-831.59% -100.32% +43.50% +239.60%
Net Margin Growth
-6.98% -9.99% -4.38% +4.81%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(29.70M) (59.49M) (33.61M) 46.92M
Preferred Dividends
- - - -
-
Net Income Available to Common
(29.70M) (59.49M) (33.61M) 46.92M
EPS (Basic)
-0.6918 -1.288 -0.6979 0.9678
EPS (Basic) Growth
-762.59% -86.18% +45.82% +238.67%
Basic Shares Outstanding
42.93M 46.19M 48.16M 48.49M
EPS (Diluted)
-0.6918 -1.288 -0.6979 0.9337
EPS (Diluted) Growth
-762.59% -86.18% +45.82% +233.79%
Diluted Shares Outstanding
42.93M 46.19M 48.16M 50.26M
EBITDA
9.89M (14.93M) 28.78M 112.20M
EBITDA Growth
-60.09% -250.89% +292.80% +289.89%
EBITDA Margin
+2.32% -2.51% +3.75% +11.51%

Snapshot

Average Recommendation BUY Average Target Price 148.25
Number of Ratings 19 Current Quarters Estimate 0.147
FY Report Date 03 / 2025 Current Year's Estimate 1.448
Last Quarter’s Earnings 0.36 Median PE on CY Estimate N/A
Year Ago Earnings 0.93 Next Fiscal Year Estimate 2.352
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 10 10 11 11
Mean Estimate 0.15 0.24 1.45 2.35
High Estimates 0.28 0.44 2.09 3.05
Low Estimate 0.02 0.00 1.01 1.67
Coefficient of Variance 57.32 51.80 22.42 19.58

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 14 14 14
OVERWEIGHT 1 1 1
HOLD 4 2 4
UNDERWEIGHT 0 1 2
SELL 0 0 0
MEAN Buy Buy Overweight

Insider Actions for Freshpet - FRPT

Date Name Shares Transaction Value
Mar 14, 2025 Jacki S. Kelley Director 11,093 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Thembeka Machaba Chief Human Resources Officer 8,870 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Nishu Patel Chief Accounting Officer 3,240 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Lauri Kien Kotcher Director 2,478 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 David B. Biegger Director 5,899 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Leta DeDe Priest Director 12,167 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Cathal Walsh SVP-Managing Director, Europe 7,574 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Todd E. Cunfer Chief Financial Officer 38,563 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Olu Fajemirokun-Beck Director 9,237 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Scott Morris President & Co-Founder 141,430 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Craig D. Steeneck Director 33,911 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 David J. West Director 4,364 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 William B. Cyr Chief Executive Officer; Director 87,551 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Lisa Alexander GC & Corp. Sec. 2,904 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Nicki Baty Chief Operating Officer 21,230 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Timothy R. McLevish Director 30,040 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Joseph E. Scalzo Director 4,040 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Daryl G. Brewster Director 57,529 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Timothy R. McLevish Director 28,608 Open market or private purchase of non-derivative security Non-derivative transaction at $106.67 per share 3,051,615.36
Feb 27, 2025 Timothy R. McLevish Director 27,358 Open market or private purchase of non-derivative security Non-derivative transaction at $102.5 per share 2,804,195.00

Freshpet in the News